China’s Qiming Venture Partners Leads $37M In AI-Enabled Drug Discovery Start-Up September 10, 2019

Insilico Medicine, a Hong Kong-based start-up specialized in next-generation artificial intelligence (AI) technology for drug discovery, has raised US$37 million in a series B round of financing led by Chinese venture capital firm Qiming Venture Partners, according to a statement released on Tuesday. Eight Roads, the US$3.5 billion venture capital fund of Fidelity International, American […]

China’s Qiming Venture Partners Leads $37M In AI-Enabled Drug Discovery Start-Up comes originally from China Money Network. All Rights Reserved.